. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » American Medical AssociationAnalgesicsAnimalsHeroin Dependence/drug therapyHumansInjections, IntramuscularInjections, SubcutaneousLegislation, DrugNalorphine/adverse effectsPentazocine/administration & dosagePentazocine/adverse effectsSubstance Withdrawal SyndromeSubstance-Related Disorders/drug therapyUnited StatesWorld Health Organization
Substances: See more » AnalgesicsPentazocineNalorphine
Year: 1973 PMID: 4740729 DOI: 10.1001/jama.1973.03220400056018
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272